Immunotargeting of glucose oxidase:: intracellular production of H2O2 and endothelial oxidative stress

被引:28
作者
Gow, AJ
Branco, F
Christofidou-Solomidou, M
Black-Schultz, L
Albelda, SM
Muzykantov, VR
机构
[1] Univ Penn, Sch Med, Med Ctr, Inst Environm Med,IFEM, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
关键词
hydrogen peroxide; drug delivery; bioconjugation; CD31; platelet-endothelial cell adhesion molecule-1;
D O I
10.1152/ajplung.1999.277.2.L271
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Extracellular and intracellular reactive oxygen species attack different targets and may, therefore, result in different forms of oxidative stress. To specifically study an oxidative stress induced by a regulated intracellular flux of a defined reactive oxygen species in endothelium, we used immunotargeting of the H2O2-generating enzyme glucose oxidase (GOX) conjugated with an antibody to platelet-endothelial cell adhesion molecule (PECAM)-1, an endothelial surface antigen. Anti-PECAM-I-125-GOX conjugates specifically bind to both endothelial and PECAM-transfected cells. Approximately 70% of cell-bound anti-PECAM-I-125-GOX was internalized. The cell-bound conjugate was enzymatically active and generated H2O2 from glucose. Use of the fluorescent dye dihydrorhodamine 123 revealed that 70% of H2O2 was generated intracellularly, whereas 30% of H2O2 was detected in the cell medium. Catalase added to the cells eliminated H2O2 in the medium but had little effect on the intracellular generation of H2O2 by anti-PECAM-GOX. Both H2O2 added exogenously to take cell medium (extracellular H2O2) and that generated by anti-PECAM-GOX caused oxidative stress manifested by time- and dose-dependent irreversible plasma membrane damage. Inactivation of cellular catalase by aminotriazole treatment augmented damage caused by either extracellular H2O2 or anti-PECAM-GOX. Catalase added to the medium protected either normal or aminotriazole-treated cells against extracellular H2O2, yet failed to protect cells against injury induced by anti-PECAM-GOX. Therefore, treatment of PECAM-positive cells with anti-PECAM-GOX leads to conjugate internalization, predominantly intracellular H2O2 generation and intracellular oxidative stress. These results indicate that anti-PECAM-GOX 1) provides cell-specific intracellular delivery of an active enzyme and 2) causes intracellular oxidative stress in PECAM-positive cells.
引用
收藏
页码:L271 / L281
页数:11
相关论文
共 32 条
[1]   MOLECULAR AND CELLULAR PROPERTIES OF PECAM-1 (ENDOCAM/CD31) - A NOVEL VASCULAR CELL CELL-ADHESION MOLECULE [J].
ALBELDA, SM ;
MULLER, WA ;
BUCK, CA ;
NEWMAN, PJ .
JOURNAL OF CELL BIOLOGY, 1991, 114 (05) :1059-1068
[2]   Ambient but not incremental oxidant generation effects intercellular adhesion molecule 1 induction by tumour necrosis factor α in endothelium [J].
Arai, T ;
Kelly, SA ;
Brengman, ML ;
Takano, M ;
Smith, EH ;
Goldschmidt-Clermont, PJ ;
Bulkley, GB .
BIOCHEMICAL JOURNAL, 1998, 331 :853-861
[3]  
BRIGHAM KL, 1986, AM REV RESPIR DIS, V133, P913
[4]  
CHOPRA J, 1987, LAB INVEST, V57, P578
[5]   OXYGEN-DEPENDENT LIPID-PEROXIDATION DURING LUNG ISCHEMIA [J].
FISHER, AB ;
DODIA, C ;
TAN, ZT ;
AYENE, I ;
ECKENHOFF, RG .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (02) :674-679
[6]  
FREEMAN BA, 1981, J BIOL CHEM, V256, P986
[7]   BRADYKININ INDUCES SUPEROXIDE ANION RELEASE FROM HUMAN ENDOTHELIAL-CELLS [J].
HOLLAND, JA ;
PRITCHARD, KA ;
PAPPOLLA, MA ;
WOLIN, MS ;
ROGERS, NJ ;
STEMERMAN, MB .
JOURNAL OF CELLULAR PHYSIOLOGY, 1990, 143 (01) :21-25
[8]   Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature [J].
Huang, XM ;
Molema, G ;
King, S ;
Watkins, L ;
Edgington, TS ;
Thorpe, PE .
SCIENCE, 1997, 275 (5299) :547-550
[9]   INTERLEUKIN-1-INDUCED LUNG NEUTROPHIL ACCUMULATION AND OXYGEN METABOLITE-MEDIATED LUNG LEAK IN RATS [J].
LEFF, JA ;
BAER, JW ;
BODMAN, ME ;
KIRKMAN, JM ;
SHANLEY, PF ;
PATTON, LM ;
BEEHLER, CJ ;
MCCORD, JM ;
REPINE, JE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (01) :L2-L8
[10]  
Louie S, 1997, Adv Pharmacol, V38, P457